{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:19:34Z","timestamp":1778887174351,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.yexmp.2020.104451","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:46:12Z","timestamp":1589471172000},"page":"104451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"115","author":[{"given":"Hongwei","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2020.104451_bb0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0010","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.chembiol.2010.08.012","article-title":"Chemical-genetic screen identifies riluzole as an enhancer of Wnt\/\u03b2-catenin signaling in melanoma","volume":"17","author":"Biechele","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182433","article-title":"The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells","volume":"12","author":"Cai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.yexmp.2020.104451_bb0020","first-page":"1423","article-title":"A positive feedback loop of long noncoding RNA CCAT2 and FOXM1 promotes hepatocellular carcinoma growth","volume":"7","author":"Chen","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexmp.2020.104451_bb0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.yexmp.2020.104451_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0140-6736(75)91142-3","article-title":"Advanced diffuse histiocytic lymphoma, a potentially curable disease","volume":"1","author":"DeVita","year":"1975","journal-title":"Lancet."},{"key":"10.1016\/j.yexmp.2020.104451_bb0035","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2015.04.021","article-title":"Interplay between microRNAs and WNT\/beta-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer","volume":"51","author":"Ghahhari","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2020.104451_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.oooo.2016.10.006","article-title":"The emerging role of long noncoding RNAs in oral cancer","volume":"123","author":"Gomes","year":"2017","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0045","first-page":"2360","article-title":"Long non-coding RNA OR3A4 promotes metastasis of ovarian cancer via inhibiting KLF6","volume":"23","author":"Guo","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.yexmp.2020.104451_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","article-title":"YY1 regulates cancer cell immune resistance by modulating PD-L1 expression","volume":"43","author":"Hays","year":"2019","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.yexmp.2020.104451_bb0055","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1038\/srep12465","article-title":"Blockade of Wnt\/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype","volume":"5","author":"Jang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2020.104451_bb0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-16-0226","article-title":"Anthelmintic niclosamide disrupts the interplay of p65 and FOXM1\/beta-catenin and Eradicates leukemia stem cells in chronic myelogenous leukemia","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2020.104451_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061479","article-title":"Targeting transcription factors for cancer treatment","volume":"23","author":"Lambert","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.yexmp.2020.104451_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2019.01.049","article-title":"LncRNA OR3A4 participates in the angiogenesis of hepatocellular carcinoma through modulating AGGF1\/akt\/mTOR pathway","volume":"849","author":"Li","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.biopha.2017.10.011","article-title":"Long non-coding RNA OR3A4 promotes proliferation and migration in breast cancer","volume":"96","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2020.104451_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cca.2018.04.013","article-title":"Prognostic value of pretreatment plasma D-dimer levels in patients with diffuse large B cell lymphoma (DLBCL)","volume":"482","author":"Liu","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.yexmp.2020.104451_bb0085","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1200\/JCO.2005.05.012","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"23","author":"Lossos","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0090","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171070","article-title":"LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells","volume":"37","author":"Mao","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.yexmp.2020.104451_bb0095","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1634\/theoncologist.2016-0103","article-title":"Lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: is it a valid treatment option?","volume":"21","author":"Mondello","year":"2016","journal-title":"Oncologist."},{"key":"10.1016\/j.yexmp.2020.104451_bb0100","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.yexmp.2020.104451_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biopha.2016.02.032","article-title":"Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma","volume":"79","author":"Peng","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2020.104451_bb0110","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2017-11-817601","article-title":"Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma","volume":"131","author":"Ren","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.yexmp.2020.104451_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2017.02.008","article-title":"Revisiting the role of Wnt\/beta-catenin signaling in prostate cancer","volume":"462","author":"Schneider","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yexmp.2020.104451_bb0120","doi-asserted-by":"crossref","first-page":"72182","DOI":"10.18632\/oncotarget.20053","article-title":"Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK\/ERK signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.yexmp.2020.104451_bb0125","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/1078-0432.CCR-16-0742","article-title":"A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion","volume":"23","author":"Xu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2020.104451_bb0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/cgt.2017.10","article-title":"lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1","volume":"24","author":"Yu","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexmp.2020.104451_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13046-018-0896-y","article-title":"LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through beta-catenin-dependent Wnt pathway","volume":"37","author":"Yu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2020.104451_bb0140","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","article-title":"FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis","volume":"20","author":"Zhang","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2020.104451_bb0145","doi-asserted-by":"crossref","first-page":"34374","DOI":"10.18632\/oncotarget.16163","article-title":"The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.yexmp.2020.104451_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41419-019-1479-3","article-title":"Lnc SMAD5-AS1 AS ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt\/beta-catenin pathway by sponging miR-135b-5p to elevate expression of APC","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexmp.2020.104451_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.08.015","article-title":"A comprehensive review of web-based non-coding RNA resources for cancer research","volume":"407","author":"Zheng","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2020.104451_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13046-019-1315-8","article-title":"Long non-coding RNA LUCAT1\/miR-5582-3p\/TCF7L2 axis regulates breast cancer stemness via Wnt\/\u03b2-catenin pathway","volume":"38","author":"Zheng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019306410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019306410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:06:10Z","timestamp":1757991970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019306410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":32,"alternative-id":["S0014480019306410"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104451","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104451"}}